BioStock article: Aptahem on schedule for clinical studies

BioStock published an article on 31 August 2022 about Aptahem, which can be read in full below. Malmö-based biotech Aptahem, which is developing the drug candidate Apta-1 as a new type of emergency treatment for sepsis, released its Q2...

Read More

BioStock article: Aptahem increasingly close to clinical studies

BioStock published an article on 15 August 2022 about Aptahem, which can be read in full below. BioStock reached out to Malmö company Aptahem, which is developing an emergency treatment for sepsis. The biotech points out that they continue...

Read More